Abstract

This study aimed to assess atrial fibrillation (AF) incidence and predictive factors in hypertensive patients and to formulate an AF risk assessment score that can be used to identify the patients most likely to develop AF. This was a cohort study of patients recruited in primary healthcare centers. Patients aged 40 years or older with hypertension, free of AF and with no previous cardiovascular events were included. Patients attended annual visits according to clinical practice until the end of study or onset of AF. The association between AF incidence and explanatory variables (age, sex, body mass index, medical history and other) was analyzed. Finally, 12,206 patients were included (52.6% men, and mean age was 64.9 years); the mean follow-up was 36.7 months, and 394 (3.2%) patients were diagnosed with AF. The incidence of AF was 10.5/1000 person-years. Age (hazard ratio [HR] 1.06 per year; 95% confidence interval [CI] 1.05–1.08), male sex (HR 1.88; 95% CI 1.53–2.31), obesity (HR 2.57; 95% CI 1.70–3.90), and heart failure (HR 2.44; 95% CI 1.45–4.11) were independent predictors (p < 0.001). We propose a risk score based on significant predictors, which enables the identification of people with hypertension who are at the greatest risk of AF.

Details

Title
A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project
Author
Orozco-Beltran, Domingo 1 ; Quesada, Jose A. 1 ; Bertomeu-Gonzalez, Vicente 2   VIAFID ORCID Logo  ; Lobos-Bejarano, Jose M. 3 ; Navarro-Perez, Jorge 4 ; Gil-Guillen, Vicente F. 1 ; Garcia Ortiz, Luis 5 ; Lopez-Pineda, Adriana 1 ; Castellanos-Rodriguez, Angel 6 ; Lopez-Domenech, Angela 1 ; Cardona-Llorens, Antonio Francisco J. 7 ; Carratala-Munuera, Concepcion 1 

 Miguel Hernandez University of Elche, Chair of Family Medicine, Clinical Medicine Department, San Juan de Alicante, Spain (GRID:grid.26811.3c) (ISNI:0000 0001 0586 4893) 
 University Hospital of San Juan de Alicante, Cardiology Department, San Juan de Alicante, Spain (GRID:grid.26811.3c); Miguel Hernandez University, Clinical Medicine Department, San Juan de Alicante, Spain (GRID:grid.26811.3c) (ISNI:0000 0001 0586 4893); CIBER Cardiovascular CB16/11/00420, Madrid, Spain (GRID:grid.512890.7) 
 Jazmin Primary Care Health Center, Madrid, Spain (GRID:grid.512890.7) 
 Valencia Clinical Hospital, Department of Internal Medicine, Valencia, Spain (GRID:grid.512890.7); INCLIVA Research Institute, Valencia, Spain (GRID:grid.512890.7); University of Valencia, Department of Medicine, Valencia, Spain (GRID:grid.5338.d) (ISNI:0000 0001 2173 938X) 
 University of Salamanca, Cardiovascular Research Group of Castilla y León, Health Center La Alamedilla de Salamanca, Salamanca, Spain. Research Network in Preventive Activities and Health Promotion (REDIAPP). Department of Biomedical and Diagnostic Sciences, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817) 
 Ciudad Periodistas Primary Care Health Center, Madrid, Spain (GRID:grid.26811.3c) 
 Miguel Hernandez University of Elche, Pathology and Surgery Department, San Juan de Alicante, Spain (GRID:grid.26811.3c) (ISNI:0000 0001 0586 4893) 
Pages
4796
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2850929297
Copyright
© The Author(s) 2020. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.